We caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from those made in or suggested by the forward-looking statements contained in this communication.
MECHANISMS OF ACTION OF GLP-1 RAs AND MULTI-AGONIST THERAPIES Incretin-based therapies leverage the physiological roles of gut-derived peptide hormones, principally glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor (GCG) to address the multifaceted pathophysiology of MASLD
It comes in four dosage strengths: 3.75 mg phentermine / 23 mg topiramate (starting dose, taken for 14 days) 7.5 mg phentermine / 46 mg topiramate (recommended dose) 11.25 mg phentermine / 69 mg topiramate (titration dose) 15 mg phentermine / 92 mg topiramate (top dose) The dosing follows a gradual escalation
With regular use and lifestyle adjustments, GLP-1 injections provide a safe and effective way to support long-term weight loss and overall health
any medical condition, consult your doctor before use